A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

PG Rose, VL Brunetto, L VanLe, J Bell, JL Walker… - Gynecologic …, 2000 - Elsevier
Background. Some endometrial cancers are hormonally dependent. A principal source of
circulating estrogen is conversion of adrenal androstenedione by aromatase. Anastrozole …
被引用次数：261 相关文章

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

PG Rose, VL Brunetto, L VanLe, J Bell, JL Walker… - Gynecologic …, 2000 - infona.pl
Background. Some endometrial cancers are hormonally dependent. A principal source of
circulating estrogen is conversion of adrenal androstenedione by aromatase. Anastrozole …

[引用][C] A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group Study

R GP - Gynecol Oncol, 2000 - cir.nii.ac.jp
A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : a
Gynecologic Oncology Group Study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[引用][C] A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study1

PG ROSE, VL BRUNETTO, L VANLE… - Gynecologic …, 2000 - pascal-francis.inist.fr
A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma : A
gynecologic oncology group study1 CNRS Inist Pascal-Francis CNRS Pascal and Francis …

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study

PG Rose, VL Brunetto, L VanLe, J Bell… - Gynecologic …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Some endometrial cancers are hormonally dependent. A principal source of
circulating estrogen is conversion of adrenal androstenedione by aromatase. Anastrozole …

A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

PG Rose, VL Brunetto, L VanLe… - Gynecologic …, 2000 - gynecologiconcology-online.net
Background. Some endometrial cancers are hormonally dependent. A principal source of
circulating estrogen is conversion of adrenal androstenedione by aromatase. Anastrozole …

A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

PG Rose, VL Brunetto, L VanLe, J Bell… - Gynecologic …, 2000 - europepmc.org
Background Some endometrial cancers are hormonally dependent. A principal source of
circulating estrogen is conversion of adrenal androstenedione by aromatase. Anastrozole …

[引用][C] A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study

PG Rose, VL Brunetto, L VanLe, J Bell, JL Walker… - Gynecologic …, 2000 - cir.nii.ac.jp
A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A
Gynecologic Oncology Group Study | CiNii Research CiNii 国立情報学研究所 学術情報 …

[引用][C] A Phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: A gynecologic oncology group study1

PG ROSE, VL BRUNETTO, L VANLE, J BELL… - Gynecologic …, 2000 - Elsevier